Results 31 to 40 of about 485,392 (348)

Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer: a plain language summary of the DESTINY-Breast04 study

Future Oncology
Plain Language Summary What is this summary about? This is a summary of the publication about the DESTINY-Breast04 study, which was published in the New England Journal of Medicine in July 2022.
S. Modi
semanticscholar   +1 more source

Plain Language Summary on The European Union One Health 2022 Zoonoses Report

EFSA journal. European Food Safety Authority, 2023
This publication is linked to the following EFSA Journal article: https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2023 ...
L. Almeida, F. Correia, M. Hempen, W. Messens, S. Antoniou, Francesca Baldinelli, A. Broglia, L. Kohnle, Lina Mur, Taina Niskanen, M. Afzal, T. Bakonyi, Veronica Cristea, Istituto Superiore, Di Sanita, Gaia Scavia, Ilaria Altieri, Fabrizio Anniballi, Pierfrancesco Barbariol, A. Bella, Simone M. Cacciò, A. Casulli, Alessandra Ciervo, E. Delibato, M. Dente, Michele Luca D'Errico, A. Garcia, Mariana Fernandez, Francesca Gomez Morales, Federico Iacoponi, M. Giannoni, Claudia Lalle, C. Lucarelli, Stefano Marianelli, M. Morabito, Ortoffi Flavia, Elisabetta Riccardo, Rosangela Suffredini, Eleonora Tozzoli, Ventola Laura, V. Istituto, Zooprofilattico delle Venezie Giorgia, Lisa Angeloni, Grazia Barco, A. Manca, Katia Boscolo, Capello Giulia, Laura Cento, Paola Ciot, Laura De Benedictis, Annie Gagliazzo, Elena Ishebabi, Monica Lazzaro, Marzia Lorenzetto, Claudio Mancin, A. Mantovani, Martina Sardella, Simona Marica, Toson Istituto, Zooprofilattico Sperimentale, dell'Abruzzo, del Molise, ‘G. Caporale’, P. Calistri, Marta Cresci, Enrico De Albentiis, G. Garofolo, D. Palma, F. Massis, F. Pomilio, A. Bonanni, Susanna Tora, A. D. Lorenzo, Mauro Ferella, Andrea De Ruvo, R. Lucchini, Annamaria Conte, Istituto Zooprofilattico, Sperimentale della Lombardia, '. EmiliaRomagna, B. María, Beatrice Boniotti, N. Vicari, S. Bellini, Gabriele Casadei, A. Asséré, Christophe Cordevant, Aurélie Couesnon, R. Blaga, F. Cliquet, Corinne Danan, Nolwenn Dheilly, L. Freddi, Gaëlle Gonzalez, C. Ponsart, Dana Pottratz, E. Robardet, É. Rousset, Isabelle Vallée   +98 more
semanticscholar   +1 more source

Plain language summary: efficacy and safety of gepotidacin, a new oral antibiotic, compared with nitrofurantoin, a commonly used oral antibiotic, for treating uncomplicated urinary tract infection

Future Microbiology
Plain Language Summary What is this summary about? Gepotidacin is a new oral antibiotic that is under investigation as a treatment for certain infections.
Florian M. Wagenlehner, C. Perry, T. M. Hooton, N. Scangarella-Oman, Helen Millns, Salim Janmohamed, M. Kramer, Pamela Kushner, Marcy Powell, E. Jarvis, Jeremy Dennison, Amanda J. Sheets, Deborah L Butler, John Breton   +13 more
semanticscholar   +1 more source

Comparing how well abrocitinib and dupilumab treat atopic dermatitis signs and symptoms: a plain language summary.

Immunotherapy, 2023
WHAT IS THIS SUMMARY ABOUT? Atopic dermatitis (AD, also called atopic eczema) is a skin disease that that can affect a person for a long time and causes red or flaky skin that can be itchy and uncomfortable.
K. Reich, J. Thyssen, A. Blauvelt, K. Eyerich, W. Soong, Z. Rice, H. Hong, N. Katoh, F. Valenzuela, M. Dibonaventura, Tamara A Bratt, Fan Zhang, C. Clibborn, R. Rojo, H. Valdez, U. Kerkmann   +15 more
semanticscholar   +1 more source

Using artificial intelligence to expedite and enhance plain language summary abstract writing of scientific content

JAMIA Open
Objective To assess the capacity of a bespoke artificial intelligence (AI) process to help medical writers efficiently generate quality plain language summary abstracts (PLSAs). Materials and Methods Three independent studies were conducted. In Studies 1
D. McMinn, Tom Grant, Laura DeFord-Watts, Veronica Porkess, Margarita Lens, Christopher Rapier, Wilson Joe, Timothy A Becker, W. Bender   +8 more
semanticscholar   +1 more source

Long-term effectiveness of ARRY-371797 in people with dilated cardiomyopathy and a faulty LMNA gene: a plain language summary.

Future Cardiology, 2023
WHAT IS THIS PLAIN LANGUAGE SUMMARY ABOUT? This summary explains the results of a long-term extension study on the effects of a specific medicine. A long-term extension study allows people who have already completed a research study to continue taking ...
D. Judge, Matthew R. G. Taylor, Huihua Li, Colleen Oliver, F. Angeli, Patrice A Lee, C. Macrae   +6 more
semanticscholar   +1 more source

Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer).

Future Oncology, 2023
WHAT IS THIS SUMMARY ABOUT? This is a summary of results from a phase 3 clinical study called HIMALAYA. HIMALAYA looked at treatment with one dose of a medication called tremelimumab combined with multiple doses of a medication called durvalumab (the ...
G. Abou-Alfa, G. Lau, Masatoshi Kudo, S. Chan, R. Kelley, J. Furuse, W. Sukeepaisarnjaroen, Y. Kang, T. V. Dao, E. D. De Toni, L. Rimassa, V. Breder, Alexander Vasilyev, A. Heurgué, V. Tam, K. Mody, S. Thungappa, Y. Ostapenko, T. Yau, Sergio Azevedo, María Varela, A. Cheng, S. Qin, P. R. Galle, Sajid Ali, C. Gupta, M. Makowsky, J. Kurland, A. Negro, B. Sangro   +29 more
semanticscholar   +1 more source

Plain Language Summary of Publication of the safety and efficacy of ARRY-371797 in people with dilated cardiomyopathy and a faulty LMNA gene.

Future Cardiology, 2023
WHAT IS THIS PLAIN LANGUAGE SUMMARY ABOUT? This plain language summary describes the results of a study looking at the effects of a medicine called ARRY-371797 (also known as PF-07265803) in people with dilated cardiomyopathy (DCM for short) caused by a ...
C. Macrae, Matthew R. G. Taylor, L. Mestroni, J. Moses, E. Ashley, M. Wheeler, N. Lakdawala, R. E. Hershberger, Victor Sandor, Michael E. Saunders, Colleen Oliver, Patrice A Lee, D. Judge   +12 more
semanticscholar   +1 more source

Pegcetacoplan for the treatment of geographic atrophy due to age-related macular degeneration: a plain language summary of OAKS and DERBY clinical studies

Immunotherapy
Plain Language Summary What is this summary about? This is a summary of the results of 2 clinical studies , called OAKS and DERBY, that tested a medicine called pegcetacoplan. Pegcetacoplan is the first United States Food and Drug Administration (US FDA)
Jeff Heier, Eleonora M Lad, F. Holz, Philip J. Rosenfeld, Robyn H. Guymer, D. Boyer, Federico Grossi, C. Baumal, J. Korobelnik, Jason Slakter, Nadia K. Waheed, Ravi Metlapally, Ian Pearce, N. Steinle, Aníbal Francone, Allen Y. Hu, D. Lally, Pascal Deschatelets, C. Francois, Caleb Bliss, G. Staurenghi, J. Monés, Rishi P. Singh, Ramiro Ribeiro, Charlie C. Wykoff   +24 more
semanticscholar   +1 more source

Long-term survival in people with transthyretin amyloid cardiomyopathy who took tafamidis: A Plain Language Summary.

Future Cardiology, 2023
WHAT IS THIS PLAIN LANGUAGE SUMMARY ABOUT? This summary presents the results from an ongoing, long-term extension study that followed an earlier study called ATTR-ACT. People who took part in this extension study and ATTR-ACT have a type of heart disease
P. Elliott, B. Drachman, S. Gottlieb, J. Hoffman, S. Hummel, D. Lenihan, B. Ebede, B. Gundapaneni, Benjamin Li, M. Sultan, Sanjiv J. Shah   +10 more
semanticscholar   +1 more source